Viewing Study NCT05513703

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:35 PM
Ignite Modification Date: 2026-05-17 @ 5:31 PM
Study NCT ID: NCT05513703
Status: TERMINATED
Last Update Posted: 2025-10-24
First Post: 2022-08-23
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: A Study to Assess Disease Activity of Intravenously (IV) Infused Telisotuzumab Vedotin in Adult Participants With Advanced/Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Sponsor: AbbVie
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non Small Cell Lung Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None c-Met NSCLC View
None Telisotuzumab Vedotin View
None ABBV-399 View
None Cancer View
None Non Small Cell Lung Cancer View
None NSCLC View
None MET Amplified NSCLC View